The Body Already Speaks in Peptides

The short version

A peptide is a short chain of amino acids — the same building blocks proteins are made from, just far fewer of them strung together. Cells already use thousands of these short chains as messengers: signals that travel from one tissue to another and tell a receptor to do something specific, the way a gut hormone tells the brain "stop eating" or a pituitary cell releases a hormone in response to a five-second chemical knock at its door.

The five compounds on this site are research peptides built on that same messenger logic. Semaglutide extends a gut-hormone signal that already exists in the body. Ipamorelin knocks on a receptor the stomach hormone ghrelin normally uses. GHK-Cu is a copper-carrying signal your own plasma makes less of as you age. PT-141 borrows a brain receptor that ordinarily responds to a pigment-and-appetite hormone. MOTS-c is a signal your mitochondria — the power plants inside your cells — encode and release under stress. None of this is a sales pitch. This is a literature digest: it reports what has been studied, in what species, at what result, with a citation attached to every number, and it never tells a reader what dose to take.

Peptides as chemical messengers

Reading these five side by side works because they share one structural idea even though their biology is entirely different. A messenger peptide does three things: it is released somewhere, it travels (through blood, across a synapse, or between compartments of a single cell), and it locks onto a receptor shaped to recognize it. What varies is the sender, the distance, and the receiver.

• Semaglutide rides the bloodstream from an injection site to receptors on pancreatic and brain cells, mimicking a hormone the gut releases after a meal ^[4].
• Ipamorelin signals the pituitary gland directly, triggering a single pulse of growth hormone release through the same receptor ghrelin uses ^[11].
• GHK-Cu signals dermal and other tissue cells locally, carrying a copper ion that participates in tissue-repair chemistry, and its natural plasma level is itself a signal that falls with age ^[16].
• PT-141 signals inside the brain, activating melanocortin receptors concentrated in hypothalamic circuits tied to desire, distinct from drugs that act on blood vessels ^[19].
• MOTS-c is unusual even among messengers: it is encoded in mitochondrial DNA, released under metabolic stress, and can travel to the cell's own nucleus to change which genes get read ^[27].

Each page below treats its compound on its own terms — its own mechanism, its own trial record, its own regulatory status — because a shared metaphor is not a shared risk profile, and this desk does not blur that line.

What are research peptides?

"Research peptide" is a supply-chain label, not a biological one. It describes material sold for laboratory use, without the manufacturing, purity, and dosing controls that apply to an approved pharmaceutical. Two of the five compounds here — semaglutide and PT-141 — are also sold in FDA-approved prescription form for specific indications; ipamorelin, GHK-Cu (in injectable or oral form), and MOTS-c have no FDA-approved human indication at all. Where an approved product exists, this site cites the approved label and the trials that supported it. Where none exists, it says so plainly and reports only what was studied in cited human, animal, or cell research — never a recommended human dose, never a purchase pathway.

How to use this desk

Each compound gets its own page: what it is, how it works, what the controlled research found, what people report anecdotally (always labeled as such), and the cited safety cautions. The comparison page lines up all five side by side on mechanism, evidence maturity, and regulatory status. The FAQ answers the questions people bring to these compounds most often, and every reference cited anywhere on the site is collected once, numbered, on the references page.